SLC5A2 and chronic kidney disease: We searched the PubMed® (National Library of Medicine, Bethesda, MD, USA) and Web of ScienceTM (ClarivateTM, Philadelphia, PA, USA) databases for randomized controlled trials (RCTs) of SGLT2 inhibitors in CKD patients and built the database starting in January 2023.